Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions

Abstract

The present invention relates to a method for treating skin diseases and skin conditions in a patient in need thereof which comprises of administering a therapeutically effective amount of a pharmaceutical composition comprising a therapeutically effective amount of 7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline, or its individual enantiomers or the tautomers thereof, or a pharmaceutically acceptable salt thereof.

What is claimed is: 
     
         1 . A method for alleviating discomfort associated with an aesthetic, plastic surgery or cosmetology procedure in a patient in need thereof, the method comprising treating the patient with a pharmaceutical composition comprising a therapeutically effective amount of 7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline, or an individual enantiomer thereof, or an individual tautomer thereof, or a pharmaceutically acceptable salt of any one of the foregoing. 
     
     
         2 . The method of  claim 1 , wherein the procedure is selected from dermal filler injections, neurotoxin injections, Botulinum toxin injections, laser procedures, breast augmentations, breast lifts, breast reductions, face lifts and tummy tucks. 
     
     
         3 . The method of  claim 1 , wherein the pharmaceutical composition further comprises an anesthetic. 
     
     
         4 . The method of  claim 3 , wherein the anesthetic is lidocaine. 
     
     
         5 . The method of  claim 1 , wherein the pharmaceutical composition comprises a therapeutically effective amount of (S)-(+)-7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline. 
     
     
         6 . The method of  claim 1 , wherein said pharmaceutical composition is in a formulation suitable for direct injection.